Sprinkle coins every day

After the simple ceremony, the meeting will be considered as the main topic, mainly by the group president Lu Kai, who will focus on the latest progress of some recent investment mergers and acquisitions.

"Last Thursday, on behalf of the Nebula Group, the group headquarters, together with the Dream Fund, formally signed an acquisition agreement with Ma Daxiqi. The purchase price is 5 million US dollars. The Nebula Group holds 45% of the shares, and the Dream Fund holds 55% of the shares."

In other words.

Nebula Group only needs to pay US$2.25 million for the acquisition of Ma Daxiqi.

Equivalent to about 15 billion funds.

It can be seen that Ma Daxiqi itself is not worth much, and the market value is even less than 30 billion.

The purchase price of US$[-] million is already a premium purchase.

After all, although Madasic has a glorious history, it is a company that has already faded away, otherwise it would not be sold.

The most valuable part of Madasic is not the order or technology, but a large number of excellent engineers and long-term accumulated experience in aero engine research and development.

Especially the latter is the most precious and what China lacks the most.

The design, development and production of aero-engines is a long-term process of technology accumulation, and there are basically no shortcuts.

Bringing doctrine, at this time, is even more precious.

"Signing the acquisition contract is only the first step of this acquisition, and it is not time to celebrate the victory. Next, the most important thing is to get Madashic's production lines, technical materials, engineers, and even some supporting equipment as soon as possible. The factories were all relocated to the Shancheng aero-engine production base."

Zhang Shuo knew very well that the real essence of this takeover battle was the digestion of Ma Daxiqi.

It may fall short at any time.

"The aero-engine production base in Shancheng must also advance simultaneously and rapidly. It must increase capital investment and speed up the recruitment of relevant personnel, and strive to achieve initial success within one year."

Zhang Shuo turned his head and told Gu Mingzhang.

The failure of the Huaxia company in the original time and space to acquire Ma Daxiqi, in addition to the repetition of Jifu Ross, there is another very important factor, that is, the company's own lack of strength.

The starting point is also very impure.

The company's acquisition of Madasic is not really to bet on the aero-engine industry, but just to use this as a gimmick to sell the concept so that the parent company can facilitate financing.

This also leads to say.

The company's so-called investment of 200 billion yuan in the mountain city to build an aero-engine production base is a complete scam. It did nothing but defraud local subsidies.

Sadly, similar scam companies, leather bag companies, are not uncommon in China.

Fortunately, the way of heaven is fair, and retribution is not good.

In the original time and space, the company finally tasted the bitter fruit, and finally went to the tragic end of bankruptcy.

Germination never repeats its mistakes.

Especially at the moment when the budding group has the most abundant funds, Zhang Shuo is also determined to pour 200 billion real money into the production base.

If not enough, follow-up can continue to add investment.

With the current strength of the Germinal Group, it is absolutely possible to continue the blood transfusion to the Nebula Group without worrying about the issue of profitability, so that it can plan the research and development and production of aero-engines in the long run.

This is the right way! ! !

"Chairman, don't worry, the Shancheng aero-engine production base project has completed the site selection, land delivery and exploration work, and is currently in the detailed design stage."

"Within one year, the entire base project will bear initial results."

Gu Mingzhang was also guaranteed.

After all, China is an infrastructure madman. As long as the construction funds are sufficient, whether it is infrastructure such as roads, water and electricity, or plant construction, including the installation and commissioning of production lines, etc., it can be carried out quickly.

The speed of construction is absolutely beyond imagination.

"That's good!"

With Gu Mingzhang's guarantee, Zhang Shuo felt relieved, and said with a smile: "When the base starts to lay the foundation stone, remember to inform me that I will attend the site in person."

To do so, of course, is also to show the budding sincerity to the mountain city.

"Of course that would be great."

Gu Mingzhang was also very excited, he was too aware of the influence of the big boss.

Definitely the top of the line.

With Zhang Shuo's personal endorsement, Nebula Group will definitely be able to avoid many detours and unnecessary troubles in the subsequent negotiation and cooperation process with Shancheng.

Lu Kai then reported, took out a list of pharmaceutical companies, and introduced: "According to the spirit of the chairman's instructions, the group plans to acquire a large and medium-sized pharmaceutical company to set foot in the biopharmaceutical industry. Afterwards, three more suitable acquisition targets were identified.”

Zhang Shuo took the list, and at first glance locked on Hengrui Pharmaceutical, which was ranked last.

Because I have an impression!

Headquartered in Haizhou City, Jiangbei Province, Hengrui Pharmaceuticals is mainly engaged in the R&D, production and sales of antineoplastic drugs, surgical drugs and interventional imaging products.

It's also an amazing company, at least in the stock market.

The market value of Hengrui Pharmaceuticals exceeded 4000 billion at its peak, and it was known as Moutai in the pharmaceutical industry.

Then, in just two years, the market value was cut in half, leaving only a little over 2000 billion.

And in 14 years.

That is, at the current time point, the market of Hengrui Pharmaceutical can break through 460 billion.

In other words.

Even if the stock price is at a low level, compared with 14, the market value has increased by more than five times.

The crazy feedback from the stock market in the next few years may not represent everything, but it also reflects from the side that Hengrui Pharmaceutical is a genuine pharmaceutical company with huge potential.

Moreover, the sharp drop in the stock price of the former Space-Time Hengrui Pharmaceuticals is also related to the centralized procurement environment.

"Just Hengrui Pharmaceuticals!"

Zhang Shuo activated the "Prophet" talent again, and came up with a move of arbitrariness.

"Ok."

Lu Kai also followed good advice and explained to the other executives present: "Among the three pharmaceutical companies, although Hengrui Pharmaceutical's valuation is the lowest, it has a very significant advantage, that is, it pays great attention to research and development. And it is dedicated For research and development, especially the research and development of new drugs, it has never stopped."

In other words.

The characteristics of Hengrui Pharmaceutical are also in line with the corporate value orientation of Sprout Group.

A suitable acquisition target indeed.

"But this Hengrui Pharmaceutical has been listed in Shanghai since [-], and its shareholding structure is relatively scattered. It is not easy to acquire it?" Lu Qi asked.

Regardless of the fact that Hengrui Pharmaceutical’s original space-time exit was 17 years later, but in fact, this is an old pharmaceutical company in China. It was established in 1970 and still has a lot of heritage.

It is not too anxious to go public in [-].

"Trouble is definitely trouble, but it's not a big problem."

Lu Kai did it lightly, not to mention that he often did this kind of work when he was in the Thief Group, even after he came to the Germination Group, he also handled many acquisitions of listed companies.

For example, in conjunction with Ali, the privatization and delisting of Haode Map.

"The preliminary plan is to first acquire the outstanding shares of Hengrui Pharmaceuticals through dozens of investment companies, and then launch a tender offer for Hengrui Pharmaceuticals when the share capital reaches or approaches the critical point that needs to be disclosed."

According to stock market rules, if the share capital of a single investment institution exceeds 5%, it needs to be disclosed to the outside world.

However, if several companies, or even dozens of companies, are operating at the same time, in theory, the share capital needs to reach or exceed 30% before disclosure is required.

The reason why it is said is that in theory, the tradable shares of Hengrui Pharmaceutical itself are limited, and more than [-]% of the share capital is in the hands of the top ten major shareholders.

If you really want to absorb it on a large scale in the secondary market, it will inevitably cause abnormal fluctuations in stock prices.

I can't hide it even if I want to.

Moreover, this operation took a long time, and it did not conform to the behavior style of the Germination Group.

Therefore, while absorbing tradable shares in the secondary market, Germination Investment can also approach the major shareholder of Hengrui Pharmaceuticals to explore the possibility of directly acquiring the shares held by the major shareholder.

It was at the end that a takeover offer was launched for Hengrui Pharmaceuticals.

"For the acquisition of Hengrui Pharmaceuticals this time, the group does not seek to acquire 100% of the shares. It only needs to hold more than half of the shares, even if the predetermined goal is achieved." Zhang Shuo also lowered the acquisition threshold in due course.

He didn't want to say that Germination Group became a barbarian in the pharmaceutical industry.

Aggressive from the start.

For a well-established company like Hengrui Pharmaceutical, the internal interests are intertwined. In addition to the founder Sun Yang, other major shareholders include some investment institutions in Haizhou, the pharmaceutical industry, and the financial industry.

Many have official backgrounds.

Therefore, Zhang Shuo did not expect to buy 100% of Hengrui Pharmaceutical, especially the founder Sun Yang, who played a pivotal role in the development of Hengrui Pharmaceutical.

It must be stayed, and it must be entrusted with important tasks.

"My suggestion is that the acquisition of Hengrui Pharmaceuticals this time is not in the name of the group headquarters, but to register another group subsidiary, which will be fully responsible for the group's pharmaceutical business."

In addition to biopharmaceuticals, when the conditions are ripe in the future, Zhang Shuo also wants to acquire one or two companies engaged in the research and development and production of medical devices, so as to make up for Huaxia's shortcomings in this area.

You must know that the advanced medical equipment that Huaxia imports from overseas every year is also an astronomical figure.

The future is definitely promising! ! !

The so-called mature conditions do not mean that there is a lack of money, but that the principle of gradual and orderly progress must be followed.

First implement the acquisition of Hengrui Pharmaceuticals, and then consider expanding the segmented business in this field after you really get the admission ticket to the pharmaceutical industry.

Instead of doing everything as soon as it comes up, buying and buying everything, pursuing big and comprehensive.

If you take too big a step, you will tear yourself apart.

"Well, the newly established subsidiary of the group is called Lime Group. In addition to holding Hengrui Pharmaceuticals in the future, some pharmaceutical companies previously invested by the group have also been transferred to Lime Group."

In this way, the various business lines of the Germination Group can be straightened out, so that there will be no intersection.

At the same time, this is also a continuation of the "decentralization" strategy of the Sprout Group. The group's headquarters mainly manages assets, and the specific business lines are all delegated to the subsidiary level.

When each group subsidiary can operate independently, Germinal can easily hide behind the scenes.

Not too conspicuous!

Although, the second uncle had promised before that, as long as the Germination Group's operations are compliant and legal, no matter which industry it is involved in, no matter how large it is, it will be fine.

But what should be paid attention to should be paid attention to.

Zhang Shuo himself does not want to be the focus of constant attention, even vigilance.

How tiring is that life?

"Then, chairman, who is in charge of the business of the pharmaceutical sector of the group?" Lu Kai asked for instructions.

This is, after all, a new business.

Although Senior Vice President Gu Mingzhang is in charge of the manufacturing industry, the pharmaceutical sector does not seem to have much to do with the manufacturing industry, and the burden on Gu Mingzhang's shoulders is already heavy enough.

It is really inappropriate to add new responsibilities.

"You will be responsible for the preparation of Lime Group in the early stage, and we will talk about it later."

Zhang Shuo's favorite candidate for the president of Lime Group is actually Sun Yang, the founder of Hengrui Pharmaceuticals, but the acquisition of Hengrui Pharmaceuticals has just started, so it is not appropriate to talk too much.

It can only be pressed first.

In the future, how Lime Group will get involved in the medical device sector will also be subject to Sun Yang's professional advice.

This is also very important.

Even the acquisition of Ma Daxiqi and the establishment of Nebula Aero Engine Co., Ltd. itself are based on Nebula Technology, and it is related to such professionals behind the scenes.

Otherwise, Zhang Shuo would not dare to be so radical.

"Ok!"

Lu Kai also readily agreed. Lime Group's early work, one is to acquire Hengrui Pharmaceuticals, and the other is to straighten out the equity relationship with Mengya Investment, all of which are within the scope of his business.

It is also a matter of course.

Chapter 449 Pingguo provokes, Maili fights back, and the second master wants to quit! ! !

The online car-hailing turmoil did not end with the sudden emergence of Qingcheng Taxi.

4 month 16 day.

Relevant departments in Yangcheng officially issued the first local online car-hailing management method, which clearly stipulates the management of online car-hailing drivers, platform supervision responsibilities, and platform operation data security.